In conclusion, these experiments demonstrate that the combined inhibition of NLRP3 and FLT3 significantly increases apoptosis specifically in FLT3-ITD/NLRP3+ AML cells as compared to the single treatments. Here, NLRP3 is linked to acute myeloid leukemia.